Arcadia Biosciences, Inc.
RKDA
$0.92
-$0.11-10.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.32M | -2.34M | -5.07M | -7.54M | -2.02M |
| Total Depreciation and Amortization | 45.00K | 154.00K | 323.00K | 473.00K | 654.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.74M | -2.53M | -342.00K | 1.55M | -5.09M |
| Change in Net Operating Assets | 293.00K | -26.00K | -1.00M | -2.07M | -1.55M |
| Cash from Operations | -4.25M | -4.74M | -6.09M | -7.58M | -8.01M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -8.00K | 172.00K | 317.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 250.00K | 750.00K | 3.27M | 3.27M | 7.52M |
| Cash from Investing | 250.00K | 750.00K | 3.27M | 3.45M | 7.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | 6.00K | 6.00K | 9.00K | 9.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.79M | -- | -- | -- | -- |
| Cash from Financing | 1.80M | 6.00K | 6.00K | 9.00K | 9.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.21M | -3.98M | -2.82M | -4.13M | -158.00K |